| Shares | Amount | in Capital | Deficit | Deficit | ||||||||||||||||
| Common Stock | Additional Paid | Accumulated | Total Stockholders’ | |||||||||||||||||
| Shares | Amount | in Capital | Deficit | Deficit | ||||||||||||||||
| December 31, 2022 | 26,371,519 | $ | 2,637 | $ | 11,652,094 | $ | (18,798,815) | $ | (7,144,084) | |||||||||||
| Stock-based compensation | - | - | 381,501 | - | 381,501 | |||||||||||||||
| Purchase of common stock | 18,750 | 2 | 24,998 | - | 25,000 | |||||||||||||||
| Net operating loss | - | - | - | (1,747,250) | (1,747,250) | |||||||||||||||
| March 31, 2023 | 26,390,269 | $ | 2,639 | $ | 12,058,593 | $ | (20,546,065) | $ | (8,484,833) | |||||||||||
| Stock-based compensation | - | - | 350,862 | - | 350,862 | |||||||||||||||
| Purchase of common stock | 22,500 | 2 | 29,998 | - | 30,000 | |||||||||||||||
| Net operating loss | - | - | - | (832,605) | (832,605) | |||||||||||||||
| June 30, 2023 | 26,412,769 | $ | 2,641 | $ | 12,439,453 | $ | (21,378,670) | $ | (8,936,576) | |||||||||||
| Balance | 26,412,769 | $ | 2,641 | $ | 12,439,453 | $ | (21,378,670) | $ | (8,936,576) | |||||||||||
| Stock-based compensation | - | - | 253,013 | - | 253,013 | |||||||||||||||
| Issuance of restricted stock for forgiveness of accrued salary | - | - | 1,866,445 | - | 1,866,445 | |||||||||||||||
| Stock issued for amendment to convertible note | 2,323,181 | 2,323,181 | ||||||||||||||||||
| Net operating loss | - | - | - | (1,774,189) | (1,774,189) | |||||||||||||||
| Net operating income (loss) | - | - | - | (1,774,189) | (1,774,189) | |||||||||||||||
| September 30, 2023 | 26,412,769 | $ | 2,641 | $ | 16,882,092 | $ | (23,152,859) | $ | (6,268,126) | |||||||||||
| Balance | 26,412,769 | $ | 2,641 | $ | 16,882,092 | $ | (23,152,859) | $ | (6,268,126) | |||||||||||
| NOTE III | NOTES I, II & III | NOTES I, II & III | ||||||||||
| March 1, 2023 (Issuance) | December 31, 2023 | September 30, 2024 | ||||||||||
| Dividend Rate | - | - | - | |||||||||
| Term | 0.25 | 0.25 | 0.13 | |||||||||
| Volatility | 90 | % | 90 | % | 90 | % | ||||||
| Risk-free rate | N/A | 4.70 | % | 5.00 | % | |||||||
| Probability of IPO | 60 | % | 60 | % | 60 | % | ||||||
| Derivative liability, measurement input | 60 | % | 60 | % | 60 | % | ||||||
| Derivative Liability | ||||
| Balance at December 31, 2022 | $ | 710,599 | ||
| Fair value at issuance March 1, 2023 | 55,604 | |||
| Fair value on date of amendment, net | 887,946 | |||
| Fair value change | (148,751) | |||
| Balance at December 31, 2023 | $ | 1,505,398 | ||
| Derivative liability Beginning Balance | $ | 1,505,398 | ||
| Fair value change | 53,257 | |||
| Extinguishment of derivative liability - Note II | (1,359,362) | |||
| Fair value at issuance on April 29, 2024 - Senior Secured Note | 407,494 | |||
| Fair value at issuance | 407,494 | |||
| Balance at September 30, 2024 | $ | 606,787 | ||
| Derivative liability Ending Balance | $ | 606,787 | ||
| Number of Options | Weighted Average Exercise Price | Weighted Average Contractual Term (Years) | Aggregate Intrinsic Value | |||||||||||||
| Outstanding as of December 31, 2023 | 10,336,883 | $ | 1.00 | 7.41 | $ | 3,316,119 | ||||||||||
| Granted | 297,105 | 1.33 | ||||||||||||||
| Exercised | - | - | ||||||||||||||
| Forfeited | - | - | ||||||||||||||
| Outstanding as of September 30, 2024 | 10,633,988 | $ | 1.02 | 6.25 | $ | 3,316,141 | ||||||||||
| Exercisable as of September 30, 2024 | 10,186,012 | $ | 1.01 | 6.15 | $ | 3,316,141 | ||||||||||
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| September 30, 2024 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||
| Federal contract revenue | $ | - | $ | - | $ | - | $ | - | ||||||||
| Expenses: | ||||||||||||||||
| Research and development | 91,911 | 239,458 | 291,655 | 710,063 | ||||||||||||
| General and administrative | 401,636 | 1,202,669 | 1,341,271 | 2,625,066 | ||||||||||||
| Total operating expenses | 493,547 | 1,442,127 | 1,632,926 | 3,335,129 | ||||||||||||
| Operating loss | (493,547) | (1,442,127) | (1,632,926) | (3,335,129) | ||||||||||||
| Other Income (Expenses): | ||||||||||||||||
| Interest income | 23 | 161 | 138 | 44,811 | ||||||||||||
| (Loss) gain on change in fair value of derivative liability | 9,885 | (34,086) | (53,257) | (15,458) | ||||||||||||
| Interest expense | (107,382) | (80,610) | (217,821) | (160,322) | ||||||||||||
| Gain (Loss) on extinguishment of debt | - | (217,527) | 951,868 | (887,946) | ||||||||||||
| Gain on forgiveness of accrued compensation | - | - | 40,000 | - | ||||||||||||
| Total other income (expenses), net | (97,474) | (332,062) | 720,928 | (1,018,915) | ||||||||||||
| Net loss | $ | (591,021) | $ | (1,774,189) | $ | (911,998) | $ | (4,354,044) | ||||||||
| Net loss per common share: | ||||||||||||||||
| Basic | $ | (0.02) | $ | (0.07) | $ | (0.03) | $ | (0.16) | ||||||||
| Diluted | $ | (0.02) | $ | (0.07) | $ | (0.03) | $ | (0.16) | ||||||||
| Weighted average number of common stock outstanding: | ||||||||||||||||
| Basic | 31,065,688 | 26,402,153 | 27,829,820 | 26,396,183 | ||||||||||||
| Diluted | 31,065,688 | 26,402,153 | 27,829,820 | 26,396,183 | ||||||||||||
